RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding RxSight, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 197 | 2 | 228 | +33 |
| Shares | 30.6M | 45.0K | 32.9M | +2.39M (+7.8%) |
| Value | $1.58B | $2.32M | $1.98B | +$406.1M (+25.8%) |
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (52)
Institutions that held RxSight, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (19)
Institutions that held RxSight, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Capstone Investment Advisors, LLC | 127,200 | $6.56M |
| Point72 Europe (London) LLP | 85,662 | $4.42M |
| TD Asset Management Inc | 17,140 | $884.1K |
| American International Group, Inc. | 14,012 | $722.7K |
| Fox Run Management, L.L.C. | 11,346 | $585.2K |
| ExodusPoint Capital Management, LP | 11,114 | $573.0K |
| Centiva Capital, LP | 8,726 | $450.1K |
| Dynamic Technology Lab Private Ltd | 4,797 | $247.0K |
| Dark Forest Capital Management LP | 4,476 | $230.9K |
| CI Private Wealth, LLC | 4,071 | $210.0K |
| Point72 (DIFC) Ltd | 3,476 | $179.3K |
| Point72 Asia (Singapore) Pte. Ltd. | 3,278 | $169.1K |
| Simplex Trading, LLC | 1,582 | $81.0K |
| Metropolitan Life Insurance Co | 1,500 | $77.4K |
| Granite FO LLC | 1,078 | $58.7K |
| CIBC Private Wealth Group, LLC | 443 | $22.4K |
| Group One Trading, L.P. | 282 | $14.5K |
| Mine & Arao Wealth Creation & Management, LLC. | 40 | $2.06K |
| Riggs Asset Managment Co. Inc. | 18 | $929 |
Not filed for Q2 2024 yet (2)
Institutions that held RxSight, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 26,032 | $1.34M |
| Grey Street Capital, LLC | 18,961 | $978.0K |